303 related articles for article (PubMed ID: 30525300)
1. Ethical issues in susceptibility genetic testing for late-onset neurodegenerative diseases.
Manrique de Lara A; Soto-Gómez L; Núñez-Acosta E; Saruwatari-Zavala G; Rentería ME
Am J Med Genet B Neuropsychiatr Genet; 2019 Dec; 180(8):609-621. PubMed ID: 30525300
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.
Roberts JS; Uhlmann WR
Prog Neurobiol; 2013 Nov; 110():89-101. PubMed ID: 23583530
[TBL] [Abstract][Full Text] [Related]
3. Ethical Implications of Direct-to-Consumer Hereditary Cancer Tests.
Kilbride MK; Domchek SM; Bradbury AR
JAMA Oncol; 2018 Oct; 4(10):1327-1328. PubMed ID: 30027223
[No Abstract] [Full Text] [Related]
4. Ethical issues and policy analysis for genetic testing: Huntington's disease as a paradigm for diseases with a late onset.
Lilani A
Hum Reprod Genet Ethics; 2005; 11(2):28-34. PubMed ID: 16270448
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
6. Current ethical and legal issues in health-related direct-to-consumer genetic testing.
Niemiec E; Kalokairinou L; Howard HC
Per Med; 2017 Sep; 14(5):433-445. PubMed ID: 29754566
[TBL] [Abstract][Full Text] [Related]
7. Ethical issues in ocular genetics.
Mezer E; Wygnanski-Jaffe T
Curr Opin Ophthalmol; 2009 Sep; 20(5):382-6. PubMed ID: 19587598
[TBL] [Abstract][Full Text] [Related]
8. Presymptomatic and predisposition genetic testing: ethical and social considerations.
Bove CM; Fry ST; MacDonald DJ
Semin Oncol Nurs; 1997 May; 13(2):135-40. PubMed ID: 9114482
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing and counseling: selected ethical issues.
Erlen JA
Orthop Nurs; 2006; 25(6):423-6. PubMed ID: 17130767
[TBL] [Abstract][Full Text] [Related]
10. Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.
Roberts JS; Patterson AK; Uhlmann WR
Neurobiol Dis; 2020 Jul; 141():104871. PubMed ID: 32302673
[TBL] [Abstract][Full Text] [Related]
11. Information(al) matters: bioethics and the boundaries of the public and the private.
Parker LS
Soc Philos Policy; 2002; 19(2):83-112. PubMed ID: 12678083
[No Abstract] [Full Text] [Related]
12. Ethical Considerations in Neurogenetic Testing.
Su XW; Simmons Z
Semin Neurol; 2018 Oct; 38(5):505-514. PubMed ID: 30321888
[TBL] [Abstract][Full Text] [Related]
13. Controversies and ethical issues in cancer-genetics clinics.
Harris M; Winship I; Spriggs M
Lancet Oncol; 2005 May; 6(5):301-10. PubMed ID: 15863378
[TBL] [Abstract][Full Text] [Related]
14. Key Ethical Issues in Prenatal Genetics: An Overview.
Farrell RM; Allyse MA
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):127-141. PubMed ID: 29428280
[TBL] [Abstract][Full Text] [Related]
15. Health-related direct-to-consumer genetic testing: a review of companies' policies with regard to genetic testing in minors.
Borry P; Howard HC; Sénécal K; Avard D
Fam Cancer; 2010 Mar; 9(1):51-9. PubMed ID: 19488835
[TBL] [Abstract][Full Text] [Related]
16. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
Dickens BM; Pei N; Taylor KM
CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
[TBL] [Abstract][Full Text] [Related]
17. Ethics and neuropsychiatric genetics: a review of major issues.
Hoge SK; Appelbaum PS
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1547-57. PubMed ID: 22272758
[TBL] [Abstract][Full Text] [Related]
18. Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology.
Lolkema MP; Gadellaa-van Hooijdonk CG; Bredenoord AL; Kapitein P; Roach N; Cuppen E; Knoers NV; Voest EE
J Clin Oncol; 2013 May; 31(15):1842-8. PubMed ID: 23589552
[TBL] [Abstract][Full Text] [Related]
19. Ethical issues concerning genetic testing and screening in public health.
Hodge JG
Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):66-70. PubMed ID: 14755435
[TBL] [Abstract][Full Text] [Related]
20. Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.
Ormond KE; Hallquist MLG; Buchanan AH; Dondanville D; Cho MK; Smith M; Roche M; Brothers KB; Coughlin CR; Hercher L; Hudgins L; Jamal S; Levy HP; Raskin M; Stosic M; Uhlmann W; Wain KE; Currey E; Faucett WA
Genet Med; 2019 Mar; 21(3):727-735. PubMed ID: 29976988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
